Abstract
INTRODUCTION
The reasons to study medicinal plants include the widespread use of plants in folk medicines, good safety profile of plants and their ready availability [1] . Plant resources are a veritable source of pharmaceuticals and therapeutics, but they have not been adequately documented [2] .
Traditional medicinal practice has existed in Africa and other cultures for centuries since man came into being but recently it has been neglected due to undue pressure from orthodox medical practitioners and the unscientific background of its method of operation [3] . There is renewed worldwide interest in traditional medicine which is derived from the realization that orthodox medicine is not widespread in poor countries whereas healthcare has virtually been sustained by these cultural alternatives [3] .
Diabetes is a chronic metabolic disorder which is characterized by hyperglycaemia as a result of the diminished production of insulin or mounting resistance to its action [ 
Extract preparation
The leaves of Newbouldia laevis were airdried for several days and then pulverized into fine powder. About 500 g of the powdered leaves was extracted exhaustively via marceration for 72 h with 2.8 L of 70 % absolute ethanol. Filtration was carried out using a funnel and filter paper. The extract was concentrated in an evaporating dish over a hot water bath. The yield was 38.28 %.
Drugs and chemicals
Alloxan and glibenclamide (Sigma-Aldrich, UK), and 95 % ethanol (Sosol Inc, South Africa) were used. All other chemicals and drugs used were of analytical grade.
Experimental animals
Adult albino rats and mice of both sexes and weighing 135 -255 g and 20 -30 g, respectively, were used for the study. The animals were obtained from the animal house of the Department of Pharmacology and Toxicology, University of Benin, Benin City, Nigeria. They were kept in standard cages in a well-ventilated room, fed with standard growers mash (Bendel Feeds and Flour Mills Ltd, Ewu, Edo State, Nigeria) and allowed water ad libitum.
Ethical approval for the study was obtained from the Ethical Committee on the Use of Animals for Experiments, Faculty of Pharmacy, University of Benin. The animals were handled according to the standard protocols for the use of laboratory animals [8] .
Phytochemical screening
Freshly prepared extracts of Newbouldia laevis were subjected to preliminary phytochemical screening for various constituents. The methods of analysis employed was as previously described [9, 10] .
Acute toxicity studies
The acute toxicity of the plant extract was evaluated using the method described by Lorke [11] . The mice were divided into 5 groups of 5 mice each. The first group was treated with 2 ml/kg of normal saline. This served as the control. The second, third, fourth and fifth groups were treated with the ethanol extract of the plant at doses of 1,000, 2,000, 4,000 and 8,000 mg/kg, respectively. All administrations were carried out orally via an oro-gastric syringe. The mice were then observed for 24 h for signs of toxicity and mortality. Intraperitoneal acute toxicity test was similarly carried out using the same series of doses but on separate groups of mice. [11] .
Induction of diabetes mellitus
Twenty five albino rats of both sexes weighing 135 -255g were used. The rats were fasted overnight prior to injection with alloxan dissolved in normal saline at a dose of 150 mg/kg intraperitoneally for 5 days. Rats with blood glucose levels greater than 200 mg/dl were considered diabetic and used for this investigation [12] .
Antidiabetic treatment
The alloxan-diabetic albino rats which were fasted were placed in 5 groups (groups 2 -6) of 5 rats each and treated as follows: group 1 (normal rats) received normal saline orally for 14 days; group 2 were untreated diabetic rats; groups 3, 4 and 5, which were all diabetic, received orally 100, 200, 400 mg/kg of the extract, respectively, for 14 days. The 6 th group (diabetic) received 5 mg/kg of glibenclamide orally for 14 days. These doses were selected after an initial preliminary work done using various doses on diabetic rats.
Measurement of blood glucose levels
All blood samples were collected by cutting the tail-tip of the overnight fasted rats. Blood samples for fasting blood glucose determination were collected at intervals of 2, 4, 8, 24 h and on the 14 th day following treatment. Measurement of the blood glucose level (mg/dl) was carried out using AccoChek Active blood pressure monitor and results recorded [13] .
Statistical analysis
All data were expressed as mean ± SEM and where applicable, the data were analysed statistically by Student's t-test using Graph Pad Instat software, version 2.05a. P < 0.05 was taken as indicative of significant difference.
RESULTS

Phytochemical analysis
The results on the phytochemical analysis revealed the presence of alkaloids, saponins, flavonoids, tannins and cardiac glycosides.
Acute toxicity
The sign of toxicity were noticed from 30 min to 4 h following the administration of the extract for both oral and intraperitoneal routes. There was prostration and increased sensitivity to sound after about 1 h. There was also increased feed intake after about 30 min of extract administration, followed by itching and decreased movement after about 3 h of extract administration. There was weight loss after 14 days, and death for the 1 and 8 g/kg groups after 24 h of extract administration in the oral and intraperitoneal routes, respectively. The median lethal dose (LD 50 ) was 6g/kg for the intraperitoneal route, and indeterminate for the oral route. These results are shown in Table 1 
DISCUSSION
Oral acute toxicity studies showed that the extract produced no mortality except at the dose of 8g/kg. This indicates that the extract has a wide margin of safety and LD 50 could not be ascertained since no mortality was recorded at lower doses. Intrapentoneal (ip) administration of the extract caused mortality at 2 g/kg dose, with an LD 50 of 6 g/kg which confirms the safety of the plant. Induction of diabetes using alloxan has been described as a useful experimental model for studying the effect of hypoglycemic agents [14] . Alloxan and the product of its reduction, dialuric acid, establish a redox cycle with the formation of superoxide radicals. These radicals undergo dismutation to hydrogen peroxide with a simultaneous massive increase in cytosolic calcium concentration, resulting in the destruction of pancreatic β-cells and diabetes [14] .
The untreated diabetic rats had a significantly higher (p < 0.0001) fasting blood glucose level than normal rats that received normal saline. This confirms induction of diabetes by alloxan. The results show a dose-dependent lowering of fasting blood glucose level in diabetic rats treated with different doses of the extract. This dose-dependent effect compares well with glibenclamide, the reference drug used, especially at the 400 mg/kg body weight dose, at which dose the extract produced a greater and more significant reduction of blood glucose level than 5 mg/kg glibenclamide on the 14th day. Glibenclamide is a standard drug that is routinely used in the treatment of diabetes [15] . The extract's ability to significantly reduce hyperglycemia induced by alloxan may indicate a similar mechanism with glibenclamide which, being a sulphonylurea stimulates the release of insulin [16] . Alloxan destroys pancreatic β-cells and thus reduces or completely inhibit insulin secretion resulting in hyperglycemia [14] . Hence the release of insulin by glibenclamide produces a lowering of hyperglycemia. The extract also produced a similar reduction in blood sugar level and it is probable that it also enhanced insulin secretion but this needs to be investigated in future studies. However, the presence of flavonoids in the extract may account for the observed hypoglyceamic effect since they have been found to stimulate the secretion of insulin [17] . Glibenclamide (an oral hpoglycemic agent) is known to act by enhancing exogenous insulin contribution which thus corrects deficiency in the endogenous insulin created by alloxan.
CONCLUSION
The ethanol leaf extract of Newbouldia laevis demostrated antidiabetic activity in rats and acute toxicity studies also show it to be relatively safe. The findings from this work supports its use in traditional medicine. However, further studies are required to elucidate its mechanism of action.
